{"id":1068514,"date":"2024-04-09T13:01:13","date_gmt":"2024-04-09T17:01:13","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/allogene-therapeutics-announces-q2-investor-conference-participation\/"},"modified":"2024-08-18T11:48:10","modified_gmt":"2024-08-18T15:48:10","slug":"allogene-therapeutics-announces-q2-investor-conference-participation","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/allogene-therapeutics-announces-q2-investor-conference-participation.php","title":{"rendered":"Allogene Therapeutics Announces Q2 Investor Conference Participation"},"content":{"rendered":"<p><![CDATA[SOUTH SAN FRANCISCO, Calif., April  09, 2024  (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T\u2122) products for cancer and autoimmune disease, today announced that it will participate in four investor conferences in the second quarter of 2024.]]><\/p>\n<p>Read the original post:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/04\/09\/2859999\/0\/en\/Allogene-Therapeutics-Announces-Q2-Investor-Conference-Participation.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Allogene Therapeutics Announces Q2 Investor Conference Participation\">Allogene Therapeutics Announces Q2 Investor Conference Participation<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read the original post: Allogene Therapeutics Announces Q2 Investor Conference Participation <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/allogene-therapeutics-announces-q2-investor-conference-participation.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068514","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068514"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068514"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068514\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068514"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068514"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068514"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}